Created in advance of the BioLogistics Summit in partnership with our friends at pharmaphorum.com, this exclusive report features news & commentary on the logistics of handling, storing and transporting biologics and clinical trial materials. The stories cover topics such as biosimilars, subsequent entry biologics, and new regulations.
In this eBook:
In this eBook:
- Searching for terra firma in the biosimilars and non-original biologics market
- Logistics: changing the fortunes of pharma and medical device companies
- What does the future hold for Subsequent Entry Biologics (SEBs)?
- Promoting research, innovation & competition: Clinical trial legislation in the EU